Work at this foundation?
Claim this profile to manage it and see interest from grant seekers.
New Brunswick Development Corporation is a private trust based in NEW BRUNSWICK, NJ. The foundation received its IRS ruling in 2019. The principal officer is Glen Sofo. It holds total assets of $994.5M. Annual income is reported at $10.1M. Total assets have grown from $311.5M in 2019 to $994.5M in 2024. The foundation is governed by 14 officers and trustees. Tax records are available from 2020 to 2024. Grantmaking is concentrated in New Brunswick, New Jersey. Contributions to this foundation are tax-deductible.
New Brunswick Development Corporation (DEVCO) is not a traditional grantmaking foundation — it is an operating 501(c)(3) nonprofit that executes its own programs rather than distributing grants to outside organizations. Understanding this distinction is the single most important insight for any organization seeking a relationship here. DEVCO was created in 1976 as a private urban real estate development corporation with a singular mandate: transforming New Brunswick, New Jersey through development of residential and commercial real estate in a manner beneficial to the community.
With $994 million in total assets as of FY2024, DEVCO ranks among New Jersey's most financially formidable nonprofits. However, roughly $953 million of those assets represent liabilities associated with large-scale project financing — primarily the $732 million HELIX Health & Life Science Exchange campus, for which DEVCO serves as master developer. Net assets are approximately $41 million. DEVCO's IRS Form 990 shows $0 in grants paid for FY2024 and FY2022, confirming that outward grantmaking is not its model.
The path to a productive relationship begins with demonstrating direct alignment with DEVCO's active project pipeline. Organizations in healthcare, life sciences, workforce development, or affordable housing that have a physical or operational connection to New Brunswick are best positioned. DEVCO's institutional anchor partners — Rutgers University, RWJBarnabas Health, Nokia Bell Labs (via SJP Properties), and the NJ Economic Development Authority — form the ecosystem through which DEVCO engages the broader community.
DEVCO itself receives philanthropic support from the Robert Wood Johnson Foundation ($445,500 in 2024), and operates under the sustained leadership of President Christopher J. Paladino and Chairman George R. Zoffinger. First-time engagers should approach through established institutional relationships, attend DEVCO's frequent public project milestones, and engage City of New Brunswick planning staff, who work in parallel with DEVCO on development approvals. Organizations interested in community benefit agreements, building space within DEVCO-developed facilities, or project-linked technical support should initiate dialogue with Sarah F. Clarke (EVP/Assistant Secretary, $510,538 compensation in FY2024) or Merissa A. Buczny (VP/Assistant Secretary, $458,745 in FY2024), DEVCO's primary operating officers.
DEVCO's financial structure differs fundamentally from a private grantmaking foundation. Rather than distributing grants from an endowment, DEVCO raises project-specific capital for complex urban developments and channels expenditures through program operations.
Annual program expenditures (reported as 'total_giving' in IRS filings, representing program service expenses rather than external grants) have ranged from $4.6 million (FY2019) to $7.9 million (FY2020), with a general upward trend: $5.0 million in FY2021, $6.0 million in FY2022, and $6.7 million in FY2023. These figures represent money spent executing DEVCO's development mission — staff, professional services, project costs — not grants distributed to other organizations. Grant paid lines in 990s show $0 for FY2024 and FY2022.
Total assets show a dramatic structural inflection: $311M (FY2019) → $103M (FY2020) → $161M (FY2021) → $186M (FY2022) → $965M (FY2023) → $994M (FY2024). The near-$779 million jump between FY2022 and FY2023 reflects HELIX project financing coming onto DEVCO's balance sheet as master developer — not an endowment gain. DEVCO carries $953 million in liabilities, leaving net equity of approximately $41 million.
Revenue is modest relative to the asset base: $10.1 million in FY2024 (down 16.4% from $12.1 million in FY2023) and $9.4 million in FY2022. Primary income sources are program service revenues from development activities plus contributions — predominantly the ~$496,000 annual grant from the Robert Wood Johnson Foundation (approximately $495,000–$496,500 consistently across FY2020–FY2024). Net investment income has been near zero in recent years, consistent with DEVCO's non-endowment operating model.
Officer compensation is a notable budget component: total officer compensation reached $1.9 million in FY2024 (up from $1.6 million in FY2022), representing roughly 19% of total revenue. This compensation structure reflects DEVCO's project-development model, which requires high-skill executive capacity rather than a large program staff.
The peer foundations below share DEVCO's NTEE Human Services classification but operate very differently. The comparison underscores DEVCO's unique identity as a development intermediary rather than a traditional funder.
| Foundation | State | Assets | Annual Program Exp. | Primary Focus | Application |
|---|---|---|---|---|---|
| New Brunswick Development Corp | NJ | $994M | $6.7M | Urban real estate development | Project partnership only |
| Marguerite Casey Foundation | WA | $876M | ~$40M | Family equity, community advocacy | Open LOI cycles |
| Genentech Patient Foundation | CA | $424M | ~$50M | Patient medication access | Direct patient application |
| Marie Lamfrom Charitable Foundation | OR | $374M | ~$12M | Human services, health | Invited/relationship |
| Callaway Foundation Inc. | GA | $253M | ~$15M | Community development (LaGrange, GA) | Open grants program |
| BMS Patient Assistance Foundation | NJ | $230M | ~$30M | Patient prescription assistance | Direct patient application |
The critical distinction: every peer in this table either runs an open grants program or a direct-service application channel accessible to external parties. DEVCO does not. Marguerite Casey Foundation and Callaway Foundation are the closest analogs in community development orientation — both offer competitive grant cycles that New Jersey–adjacent nonprofits might pursue as alternatives. For organizations committed to New Brunswick specifically, the Robert Wood Johnson Foundation (DEVCO's own primary funder) is the most logical conventional grant target, as RWJF's New Jersey health and community investments directly overlap with DEVCO's project geography.
DEVCO's most significant recent milestone is the structural topping-out of HELIX H-1, the first 12-story, 574,000-square-foot building of the $732 million Health & Life Science Exchange campus in downtown New Brunswick. Construction involved nearly 5,200 pieces of steel and 12,800 cubic yards of concrete, with substantial completion targeted for late 2025. Rutgers Robert Wood Johnson Medical School — relocating from Piscataway — will occupy 160,000 square feet and welcome its inaugural class in summer 2026. The Innovation HUB incubator (55,000 sq. ft.) will also anchor the building, alongside expected residents including the NJ Economic Development Authority and RWJBarnabas Health.
DEVCO also secured a groundbreaking for a new 370,000-square-foot Nokia Bell Labs facility in downtown New Brunswick (developed in partnership with SJP Properties), establishing a major deep-tech anchor for the city's emerging science corridor.
On the philanthropic side, DEVCO received $445,500 from the Robert Wood Johnson Foundation in FY2024 for ongoing redevelopment efforts, following a $49,650 livability-focused grant in FY2023. These represent DEVCO's primary external philanthropic income. Total revenue declined 16.4% in FY2024, reflecting the natural ebb between major project fee cycles. Leadership has remained stable: President Christopher J. Paladino has led DEVCO continuously, with his compensation rising from $543,281 (earliest filing on record) to $699,707 in FY2024.
Because DEVCO is an operating foundation with no public grant program, conventional grant application strategies will not succeed. There is no open RFP, no grants portal at devco.org, no downloadable application form, and no program officer managing an external grantee portfolio. Organizations that approach DEVCO with a standard grant proposal will find closed doors. The following tactics are specific to how DEVCO actually engages external partners:
Enter through anchor institutions first. DEVCO's deepest relationships are with Rutgers University, RWJBarnabas Health, and the NJ Economic Development Authority. Nonprofits in health, education, or innovation should secure a referral or develop a co-project with one of these partners before approaching DEVCO. Institutional credibility is the primary filter DEVCO applies.
Tie your pitch to a specific New Brunswick location. DEVCO's IRS-stated mission covers New Brunswick and occasionally other NJ urban communities. Statewide or regional organizations without a concrete New Brunswick footprint will not resonate. The strongest overtures reference the downtown Albany Street corridor, the HELIX campus area, or specific neighborhoods where DEVCO has active projects.
Align with HELIX-phase activities. The health and life sciences innovation economy is DEVCO's stated direction through at least 2030. Organizations that can articulate a role — workforce training pipelines for HELIX tenants, community health navigation, small business services for the Innovation HUB neighborhood — are better positioned than those with generic social services missions.
Build public presence before private outreach. DEVCO hosts groundbreakings, ribbon cuttings, and city planning events regularly. Attending these events and establishing informal familiarity with President Christopher J. Paladino and EVP Sarah F. Clarke creates the relationship context DEVCO needs before engaging new partners.
Redirect traditional grant goals to RWJF. If your goal is a philanthropic grant for New Brunswick community work, the Robert Wood Johnson Foundation — DEVCO's own primary funder — is the appropriate target. RWJF runs open grant cycles and has deep investment in New Brunswick's health and livability outcomes.
Create a free Granted account to download this report — includes application checklist, full financial data, and all grantees.
Already have an account? Sign in to download.
To develop the city of new brunswick and the state of nj including the development of residential and commercial real estate in a manner beneficial to the community.
Expenses: $5.8M
DEVCO's financial structure differs fundamentally from a private grantmaking foundation. Rather than distributing grants from an endowment, DEVCO raises project-specific capital for complex urban developments and channels expenditures through program operations. Annual program expenditures (reported as 'total_giving' in IRS filings, representing program service expenses rather than external grants) have ranged from $4.6 million (FY2019) to $7.9 million (FY2020), with a general upward trend: $5.0.
New Brunswick Development Corporation (DEVCO) is not a traditional grantmaking foundation — it is an operating 501(c)(3) nonprofit that executes its own programs rather than distributing grants to outside organizations. Understanding this distinction is the single most important insight for any organization seeking a relationship here. DEVCO was created in 1976 as a private urban real estate development corporation with a singular mandate: transforming New Brunswick, New Jersey through developme.
New Brunswick Development Corporation is headquartered in NEW BRUNSWICK, NJ.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| CHRISTOPHER J PALADINO | PRESIDENT | $700K | $128K | $828K |
| Sarah F Clarke | EVP/Assistant Secretary | $511K | $105K | $616K |
| Merrisa A Buczny | VP/Assistant Secretary | $459K | $110K | $568K |
| GLEN SOFO | TREASURER | $234K | $66K | $300K |
| DAVID G SCIARRA ESQ | DIRECTOR | $0 | $0 | N/A |
| IRA S NOVAK esq | DIRECTOR | $0 | $0 | N/A |
| GILBERT H BLITZ | DIRECTOR | $0 | $0 | N/A |
| WILLIAM j QUINN | DIRECTOR | $0 | $0 | N/A |
| DENNIS MARCO | DIRECTOR | $0 | $0 | N/A |
| STANLEY M KOSIEROWSKI | DIRECTOR | $0 | $0 | N/A |
| SERGIO IACOVITTI | DIRECTOR | $0 | $0 | N/A |
| AMY MANSUE | director | $0 | $0 | N/A |
| GEORGE R ZOFFINGER | CHAIRMAN | $0 | $0 | N/A |
| VITO R NARDELLI | VICE CHAIRPERSON | $0 | $0 | N/A |
Total Giving
N/A
Total Assets
$994.5M
Fair Market Value
$999.5M
Net Worth
$41.4M
Grants Paid
N/A
Contributions
$497K
Net Investment Income
N/A
Distribution Amount
N/A
Total: $5.9M
No individual grant records are available. Visit the foundation's 990-PF filings below for detailed grantee information.